Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diffuse Glioma Heterogeneity and Its Therapeutic Implications
James Nicholson, Howard A. Fine
Cancer Discovery (2021) Vol. 11, Iss. 3, pp. 575-590
Open Access | Times Cited: 313

Showing 1-25 of 313 citing articles:

CAR T Cell-Based Immunotherapy for the Treatment of Glioblastoma
Luke Maggs, Giulia Cattaneo, Ali Emre Dal, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 112
Glioblastoma evolution and heterogeneity from a 3D whole-tumor perspective
Radhika Mathur, Qixuan Wang, Patrick G. Schupp, et al.
Cell (2024) Vol. 187, Iss. 2, pp. 446-463.e16
Open Access | Times Cited: 67
Recent Advances in Nanoenzymes Based Therapies for Glioblastoma: Overcoming Barriers and Enhancing Targeted Treatment
Liyin Wang, Min Gu, Xiaoli Zhang, et al.
Advanced Science (2025)
Open Access | Times Cited: 3
Single-cell sequencing uncovers the mechanistic role of DAPK1 in glioma and its diagnostic and prognostic implications
Tian-Hang Yu, Y Ding, Sophia Zhao, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 2
Spatiotemporal analysis of glioma heterogeneity reveals COL1A1 as an actionable target to disrupt tumor progression
Andrea Comba, Syed Mohd Faisal, Patrick Dunn, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 63
LncRNA NEAT1 facilitates glioma progression via stabilizing PGK1
Jingshan Liang, Changtao Liu, Dezhi Xu, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 52
PDGF signaling inhibits mitophagy in glioblastoma stem cells through N-methyladenosine
Deguan Lv, Ryan C. Gimple, Cuiqing Zhong, et al.
Developmental Cell (2022) Vol. 57, Iss. 12, pp. 1466-1481.e6
Open Access | Times Cited: 51
Impact of epigenetic reprogramming on antitumor immune responses in glioma
Brandon L. McClellan, Santiago Haase, Felipe J. Núñez, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 2
Open Access | Times Cited: 37
A TGF‐β signaling‐related lncRNA signature for prediction of glioma prognosis, immune microenvironment, and immunotherapy response
Weiwei Duan, Liting Yang, Jian Liu, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 30, Iss. 4
Open Access | Times Cited: 33
Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation
Francesca Orzan, Francesca De Bacco, Elisabetta Lazzarini, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 7, pp. 1252-1266
Open Access | Times Cited: 32
Glioblastoma upregulates SUMOylation of hnRNP A2/B1 to eliminate the tumor suppressor miR-204-3p, accelerating angiogenesis under hypoxia
Qindong Guo, Fan Yang, Qingtong Wang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 2
Open Access | Times Cited: 30
METTL3-mediated m6A modification of LINC00839 maintains glioma stem cells and radiation resistance by activating Wnt/β-catenin signaling
Jianxing Yin, Fangshu Ding, Zhangchun Cheng, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 7
Open Access | Times Cited: 30
TREM2 is associated with tumor immunity and implies poor prognosis in glioma
Mingchen Yu, Yuanhao Chang, You Zhai, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 23
Biomaterials with cancer cell-specific cytotoxicity: challenges and perspectives
Zhaoyou Chu, Wanni Wang, Zheng Wang, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 17, pp. 8847-8877
Closed Access | Times Cited: 12
The role of s-palmitoylation in neurological diseases: implication for zDHHC family
Dan Liao, Yutao Huang, Dan Liu, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 9
Genetic and epigenetic instability as an underlying driver of progression and aggressive behavior in IDH-mutant astrocytoma
Timothy E. Richardson, Jamie M. Walker, Dolores Hambardzumyan, et al.
Acta Neuropathologica (2024) Vol. 148, Iss. 1
Open Access | Times Cited: 9
IL4I1 in M2-like macrophage promotes glioma progression and is a promising target for immunotherapy
Feng Ye, Lichong Wang, Yuanyou Li, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 8
Mechanistic insight into glioma through spatially multidimensional proteomics
Lei Shen, Zhourui Zhang, Pengfei Wu, et al.
Science Advances (2024) Vol. 10, Iss. 7
Open Access | Times Cited: 8
ALKBH5 facilitates tumor progression via an m6A-YTHDC1-dependent mechanism in glioma
Chenyang Wang, Ningbo Xu, Xiangyang Zhong, et al.
Cancer Letters (2025) Vol. 612, pp. 217439-217439
Closed Access | Times Cited: 1
Tumour-wide RNA splicing aberrations generate actionable public neoantigens
Darwin Kwok, Nicholas Stevers, Iñaki Etxeberría, et al.
Nature (2025)
Open Access | Times Cited: 1
CircRNF10 triggers a positive feedback loop to facilitate progression of glioblastoma via redeploying the ferroptosis defense in GSCs
Chengbin Wang, Minjie Zhang, Yingliang Liu, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 21
Advances in antibody-based drugs and their delivery through the blood-brain barrier for targeted therapy and immunotherapy of gliomas
Xin Huang, Shuyou Shi, Hongrui Wang, et al.
International Immunopharmacology (2023) Vol. 117, pp. 109990-109990
Closed Access | Times Cited: 18
Vasari Scoring System in Discerning between Different Degrees of Glioma and IDH Status Prediction: A Possible Machine Learning Application?
Laura Gemini, Mario Tortora, Pasqualina Giordano, et al.
Journal of Imaging (2023) Vol. 9, Iss. 4, pp. 75-75
Open Access | Times Cited: 17
The Glioma Immune Landscape: A Double-Edged Sword for Treatment Regimens
Sukrit Mahajan, Mirko H. H. Schmidt, Ulrike Schumann
Cancers (2023) Vol. 15, Iss. 7, pp. 2024-2024
Open Access | Times Cited: 17
Preoperative prediction of MGMT promoter methylation in glioblastoma based on multiregional and multi-sequence MRI radiomics analysis
Lanqing Li, Xiao Feng, Shouchao Wang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top